It inhibited the IFNγ-dependent Jak1/STAT1 signaling in LTo cells and endothelial cells within the spleen, thereby resulting in enhanced NF-κB signaling, increased proliferation of LTo and endothelial cells, and ultimately leading to splenomegaly [53]. The gene discussed is NFKB1; the disease is Splenomegaly.